| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Counted by filing, the last 12 months brought no open-market purchases and 3 sales by 3 insiders worth about $251K. The 12 months before that brought 9 open-market purchases by 8 insiders worth about $1.7M and 2 sales by 1 insider worth about $5.8M.
None of the 3 sales in the last 12 months was marked as made under a Rule 10b5-1 trading plan.
The largest open-market purchase in the last two years was 1,358,448 shares by Richard A Barasch (Director) at an average $1.04 on March 26, 2025, about $1.4M. Twelve months later TOI was up 156%.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 5.44M | - | - | |
| CEO | 1.80M | - | - | |
| Dir | 683.7K | - | - | |
| Dir | 333.5K | - | - | |
| Dir | 291.4K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Robert Ross Carter | Chief Financial Officer | Sell | 247 | $3.56 | $879.32 | -0.1% | -15.0% | - | |
| Dec 15, 2025 | Brad Hively79 | Director | Sell | 13,333 | $3.77 | $50,290.74 | -1.9% | -9.5% | - | |
| Nov 18, 2025 | Mark L Pacala | Director | Sell | 50,000 | $4.00 | $200,000.00 | -22.2% | -29.4% | - | |
| Sep 4, 2025 | M33 Growth I L.P. | Director, 10% Owner | Sell | 6,700,000 | $3.09 | $20,703,000.00 | -91.9% | -5.8% | - | |
| Aug 19, 2025 | Brad Hively79 | Director | Sell | 20,221 | $4.06 | $82,097.26 | -3.1% | -1.3% | - | |
| Jun 5, 2025 | M33 Growth I L.P. | Director, 10% Owner | Sell | 750,000 | $3.05 | $2,287,500.00 | -37.1% | +15.8% | +74.6% | |
| Jun 3, 2025 | Brad Hively79 | Director | Sale+OE | 1,976,137 | $2.87 | $5,672,106.03 | -76.6% | +1.6% | +49.4% | |
| May 20, 2025 | M33 Growth I L.P. | Director, 10% Owner | Sell | 2,000,000 | $2.71 | $5,425,800.00 | -59.7% | +45.3% | +43.2% | |
| Mar 26, 2025 | Daniel Virnich | Chief Executive Officer | Buy | 22,640 | $1.04 | $23,584.09 | +3.2% | +94.2% | +156.2% | |
| Mar 26, 2025 | Yale Podnos | Chief Medical Officer | Buy | 9,056 | $1.04 | $9,433.64 | +12.9% | +94.2% | +156.2% |